NEW YORK – In a recently launched observational study, San Diego-based biotech startup Persephone Biosciences is hoping to explore how cancer patients' gut microbiome composition influences their immune system and their ability to respond to treatments.
Startup Using Omics Analysis in Large Microbiome Study to Inform Cancer Therapy, CDx Development
Premium
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.